Cell line will be used in vaccine production.
Crucell and Pfizer Animal Health signed a research license agreement for PER.C6®. The deal allows Pfizer Animal Health to use the cell technology in the production of a undisclosed veterinary vaccine.
Pfizer Animal Health has an option to convert the research license into a commercial agreement.